122348

The study identified these 122,348 genomic regions as having significantly different methylation patterns (adding or removing methyl groups, which changes gene expression) between various colorectal adenoma (precancerous polyp) subtypes and normal tissue. 122,348. Hypermethylated regions (Gene silencing): 6,263. Hypomethylated regions (Gene activation): 116,050.

The study allowed for precise differentiation of molecular pathways that lead to colorectal cancer (CRC), reinforcing that distinct histological groups (SSL vs. TSA vs. VA) are driven by unique molecular machinery. If you are working on a similar research project, 122348

Identifying such a large number of specific DMRs offers potential for developing highly accurate molecular diagnostics to classify polyp risk, potentially distinguishing between aggressive polyps and benign ones. 3. Comparison and Methodology The study identified these 122,348 genomic regions as

Here is a deep guide into this finding and its clinical significance. 1. Context: What Are the 122,348 DMRs? Hypomethylated regions (Gene activation): 116,050

Each adenoma subtype was directly compared to normal tissue to identify unique methylation signatures.

The analysis involved a rigorous methodology to ensure the reliability of these findings: